The choice of epilepsy medication should be made under the guidance of a medical professional, and the appropriate antiepileptic drug is usually selected according to the type of seizure.
The drug should be gradually increased in small doses, and maintenance therapy should be followed when the desired effect is achieved. If it is difficult to use one drug alone or patients with mixed epilepsy, it is often necessary to combine drugs, but no more than 3 drugs should be combined.
Stick to long-term, regular medication and avoid stopping the medication or changing the dosage of the medication to avoid inducing re-seizures of epilepsy.
During the period of medication, regular examinations, such as liver and kidney function, blood routine, etc., should be carried out regularly to monitor the possible side effects caused by the drug.
Patients should avoid medications that may trigger seizures, such as quinolones, glucocorticoids, etc.
While taking anti-epileptic drugs, patients should pay attention to maintaining good living habits, such as a reasonable diet, adequate sleep, and avoiding overwork, so as to enhance the body's resistance and reduce the possibility of seizures.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: